Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Brassat

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Revue Neurologique|April 22, 2014
[Cerebrotendinous xanthomatosis: a multicentric retrospective study of 15 adults, clinical and paraclinical typical and atypical aspects]C Lionnet, C Carra, X Ayrignac, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 18, 2011
High-risk syndrome for neuromyelitis optica: a descriptive and comparative studyN Collongues, R Marignier, H Zéphir, et al.
American Journal of Human Genetics|October 21, 2004
A second-generation genomic screen for multiple sclerosisS J Kenealy, M-C Babron, Y Bradford, et al.
Journal of Neurology|May 2, 2015
Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric studyA Siri, Clarisse Carra-Dalliere, X Ayrignac, et al.
Genes and Immunity|March 21, 2008
IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populationsF Weber, B Fontaine, I Cournu-Rebeix, et al.
Journal of Neuroimmunology|September 6, 2011
IL28B polymorphisms are not associated with the response to interferon-β in multiple sclerosisS Malhotra, C Morcillo-Suárez, D Brassat, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 13, 2015
A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosisJ Kuhle, M Hardmeier, G Disanto, et al.
European Journal of Neurology|July 31, 2013
A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohortO Outteryck, J C Ongagna, B Brochet, et al.
Neurology|March 3, 2010
Neuromyelitis optica in France: a multicenter study of 125 patientsN Collongues, R Marignier, H Zéphir, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 15, 2015
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre studyJ Kuhle, G Disanto, R Dobson, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Revue Neurologique|April 22, 2014
[Cerebrotendinous xanthomatosis: a multicentric retrospective study of 15 adults, clinical and paraclinical typical and atypical aspects]C Lionnet, C Carra, X Ayrignac, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 18, 2011
High-risk syndrome for neuromyelitis optica: a descriptive and comparative studyN Collongues, R Marignier, H Zéphir, et al.
American Journal of Human Genetics|October 21, 2004
A second-generation genomic screen for multiple sclerosisS J Kenealy, M-C Babron, Y Bradford, et al.
Journal of Neurology|May 2, 2015
Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric studyA Siri, Clarisse Carra-Dalliere, X Ayrignac, et al.
Genes and Immunity|March 21, 2008
IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populationsF Weber, B Fontaine, I Cournu-Rebeix, et al.
Journal of Neuroimmunology|September 6, 2011
IL28B polymorphisms are not associated with the response to interferon-β in multiple sclerosisS Malhotra, C Morcillo-Suárez, D Brassat, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 13, 2015
A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosisJ Kuhle, M Hardmeier, G Disanto, et al.
European Journal of Neurology|July 31, 2013
A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohortO Outteryck, J C Ongagna, B Brochet, et al.
Neurology|March 3, 2010
Neuromyelitis optica in France: a multicenter study of 125 patientsN Collongues, R Marignier, H Zéphir, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 15, 2015
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre studyJ Kuhle, G Disanto, R Dobson, et al.
Pageof 4